Men's Health News

RSS

U.S judge awards $11.7 million to DF/HCC for large-scale prostrate cancer research

Dana Farber/Harvard Cancer Center will launch a new multi-million dollar grant award program focused on prostate cancer research. It will be administered in collaboration with the Prostate Cancer Foundation.

28 Dec 2010

Janssen files abiraterone acetate NDS with Health Canada for metastatic, advanced prostate cancer

Janssen Inc. has filed a New Drug Submission (NDS) to Health Canada for the investigational drug abiraterone acetate administered with prednisone for the treatment of metastatic, advanced prostate cancer in patients who have received prior chemotherapy containing a taxane. Submissions for abiraterone acetate have also been filed with health authorities in the United States and Europe.

23 Dec 2010

Men above age 75 with high-risk prostate cancer often under-treated

Older men with high-risk prostate cancer frequently are offered fewer - and less effective - choices of treatment than younger men, potentially resulting in earlier deaths, according to a new UCSF study.

22 Dec 2010

Wyden's cancer treatment highlights debate over health care cost vs. personal choice

Sen. Ron Wyden had surgery for prostate cancer Monday, putting himself — through no fault of his own — in the middle of a debate about diagnosis, treatment and bending the cost curve.

22 Dec 2010

Mums urged not to delay births for leave scheme

Many Australian couples are delaying having a baby in order to access the federal government’s paid parental leave scheme. The scheme begins at the start of the New Year and allows eligible parents to access up to 18 weeks pay at the minimum wage. Figures show that from January 1, 2011 an estimated 148,000 families will be eligible to receive a payment of $570 a week before tax, or $10,260 over 18 weeks.

20 Dec 2010

U of A student wins annual master's thesis competition for research on light-sensitive drug for prostate cancer

The future of cancer treatment and a University of Alberta graduate student's personal career prospects are looking bright. Weiyang Liu beat competitors from 80 of the best university graduate schools in western North America with his master's thesis on the use of a light-sensitive drug to treat prostate cancer.

20 Dec 2010

Researchers demonstrate that monensin antibiotic prevents prostate cancer cell growth

Researchers from VTT Technical Research Centre of Finland and the University of Turku have demonstrated that an antibiotic called "monensin" prevents the growth of prostate cancer cells. Monensin is used in the meat and dairy industry, for example.

20 Dec 2010

New study suggests PSA test effective for men with prostate cancer

The PSA screening test for prostate cancer is not perfect. It can indicate cancer when none is present and miss life-threatening tumors. But a new study suggests the test is more reliable in men taking dutasteride (Avodart®), a drug widely prescribed to shrink an enlarged prostate gland.

17 Dec 2010

Recordati, Nymox sign European licensing agreement for BPH investigational drug, NX-1207

Recordati and Nymox Pharmaceutical Corporation announced today the signing of a European licensing agreement for the development and commercialization of NX-1207, Nymox's Phase III investigational drug currently in clinical development in the U.S. for the treatment of benign prostatic hyperplasia (BPH).

17 Dec 2010

Concordia sociologist documents men's changing and increasingly confusing roles

"Man up!" is an emerging expression whose significance has become loaded in our society, according to Anthony Synnott, a professor at the Concordia University Department of Sociology and Anthropology. In his most recent book, Re-Thinking Men: Heroes, Villains and Victims (Ashgate), Synnott documents the increasingly confusing roles men are to assume in society.

14 Dec 2010

GTx announces Capesaris proof of concept clinical trail in men with advanced prostate cancer

BETHESDA, Md.,GTx, Inc. this weekend presented results of the Capesaris™ (GTx-758) proof of concept pharmacokinetic-pharmacodynamic (PK/PD) clinical trial at the Annual Meeting of the Society of Urologic Oncology.

14 Dec 2010

Pomegranate juice exhibits potential to prevent metastasis of prostate cancer cells to the bone

Researchers at the University of California, Riverside have identified components in pomegranate juice that both inhibit the movement of cancer cells and weaken their attraction to a chemical signal that promotes the metastasis of prostate cancer to the bone. The research could lead to new therapies for preventing cancer metastasis.

13 Dec 2010

Prostate cancer study identifies 295 genes associated with clinical recurrence following radical prostatectomy

Genomic Health, Inc. today announced the first results of a large prostate cancer study that identified 295 genes strongly associated with clinical recurrence following radical prostatectomy. Top-line findings from this study, which applied the same RT-PCR technology used in Genomic Health's Oncotype DX® breast and colon cancer tests, will be presented today at the Society for Urologic Oncology (SUO) annual meeting.

13 Dec 2010

Men with type 1 diabetes could grow their own insulin-producing cells from testicular tissue, says GUMC

Men with type 1 diabetes may be able to grow their own insulin-producing cells from their testicular tissue, say Georgetown University Medical Center (GUMC) researchers who presented their findings today at the American Society of Cell Biology 50th annual meeting in Philadelphia.

13 Dec 2010

Young gay men taking risks - raising HIV transmission

A new study on HIV transmission in Australia reveals an alarming culture shift in which younger gay men appear more willing to take sexual risks and so become infected with the virus earlier. When comparing older men who have sex with men (MSM) with those aged under 35, the younger ones were found to be more likely to have never previously been tested for HIV and more likely to report not knowing the HIV status of regular partners. These men commonly reported inconsistent condom use with casual and regular partners.

12 Dec 2010

Expert discusses androgen deprivation therapy for prostate cancer

A common prostate cancer treatment, the ‘androgen deprivation therapy’ has often been prescribed for low-risk prostate cancer patients. This therapy for treating prostate cancer had previously been blamed for increased risk of cardiovascular disease and heart conditions.

9 Dec 2010

WSJ investigation: A sharp rise in specific prostate therapy parallels high Medicare payments

Roughly one in three Medicare beneficiaries diagnosed with prostate cancer today gets a sophisticated form of radiation therapy called IMRT. …The story behind the sharp rise in the use of IMRT — which stands for intensity-modulated radiation therapy — is about more than just the rapid adoption of a new medical technology.

9 Dec 2010

MassMutual broadens life insurance underwriting guidelines for prostate cancer survivors

Building on a long-standing commitment to helping people before, during and after a cancer diagnosis, Massachusetts Mutual Life Insurance Company has broadened its life insurance underwriting guidelines for prostate cancer survivors.

8 Dec 2010

Bavarian Nordic receives SPA for Phase 3 study of PROSTVAC for advanced prostate cancer

Bavarian Nordic A/S announced today that the company has received a letter of concurrence from the U.S. Food and Drug Administration on a Special Protocol Assessment for a Phase 3 study required for product registration for its product candidate, PROSTVAC, for the treatment of patients with asymptomatic or minimally symptomatic metastatic castration-resistant prostate cancer.

8 Dec 2010

Researchers develop imaging technology that can accurately identify prostate cancer

Prostate cancer is the most common type of cancer among men, but its diagnosis has up to now been inaccurate and unpleasant. Researchers at Eindhoven University of Technology in the Netherlands, in cooperation with AMC Amsterdam, have developed an imaging technology that can accurately identify tumors.

8 Dec 2010

Men's Health News

U.S judge awards $11.7 million to DF/HCC for large-scale prostrate cancer research

Janssen files abiraterone acetate NDS with Health Canada for metastatic, advanced prostate cancer

Men above age 75 with high-risk prostate cancer often under-treated

Wyden's cancer treatment highlights debate over health care cost vs. personal choice

Mums urged not to delay births for leave scheme

U of A student wins annual master's thesis competition for research on light-sensitive drug for prostate cancer

Researchers demonstrate that monensin antibiotic prevents prostate cancer cell growth

New study suggests PSA test effective for men with prostate cancer

Recordati, Nymox sign European licensing agreement for BPH investigational drug, NX-1207

Concordia sociologist documents men's changing and increasingly confusing roles

GTx announces Capesaris proof of concept clinical trail in men with advanced prostate cancer

Pomegranate juice exhibits potential to prevent metastasis of prostate cancer cells to the bone

Prostate cancer study identifies 295 genes associated with clinical recurrence following radical prostatectomy

Men with type 1 diabetes could grow their own insulin-producing cells from testicular tissue, says GUMC

Young gay men taking risks - raising HIV transmission

Expert discusses androgen deprivation therapy for prostate cancer

WSJ investigation: A sharp rise in specific prostate therapy parallels high Medicare payments

MassMutual broadens life insurance underwriting guidelines for prostate cancer survivors

Bavarian Nordic receives SPA for Phase 3 study of PROSTVAC for advanced prostate cancer

Researchers develop imaging technology that can accurately identify prostate cancer

Leveraging the Radian ASAP in standard casework

A journey through science, software, and innovation: Insights from the Bruker software team

CellVoyant's AI-Powered Vision for the Future of Cell Therapy

Latest News